| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Chronic obstructive pulmonary disease: Is there a case for earlyintervention? |
Ramsey, S.D.;Sullivan, S.D.; |
American Journal of Medicine Supplements |
2004-12-20 |
查看 |
| The pathophysiology of airway dysfunction |
Doherty, D.E.; |
American Journal of Medicine Supplements |
2004-12-20 |
查看 |
| The role of anticholinergics in chronic obstructive pulmonary disease |
Barnes, P.J.; |
American Journal of Medicine Supplements |
2004-12-20 |
查看 |
| Lung function improvements with once-daily tiotropium in chronicobstructive pulmonary disease |
Casaburi, R.;Conoscenti, C.S.; |
American Journal of Medicine Supplements |
2004-12-20 |
查看 |
| Interventions to prevent chronic obstructive pulmonary diseaseexacerbations |
Niewoehner, D.E.; |
American Journal of Medicine Supplements |
2004-12-20 |
查看 |
| Clinically meaningful outcomes in patients with chronic obstructivepulmonary disease |
ZuWallack, R.L.;Haggerty, M.C.;Jones, P.; |
American Journal of Medicine Supplements |
2004-12-20 |
查看 |
| Acute bacterial rhinosinusitis: Clinical impact of resistance andsusceptibility |
Poole, M.D.; |
American Journal of Medicine Supplements |
2004-08-02 |
查看 |
| Streptococcus pneumoniae and community-acquired pneumonia: A cause forconcern |
File, T.M.; |
American Journal of Medicine Supplements |
2004-08-02 |
查看 |
| Review of treatment guidelines for community-acquired pneumonia |
Niederman, M.S.; |
American Journal of Medicine Supplements |
2004-08-02 |
查看 |
| Streptococcus pneumoniae: Epidemiology and patterns of resistance |
Jacobs, M.R.; |
American Journal of Medicine Supplements |
2004-08-02 |
查看 |
| Overview of newer antimicrobial formulations for overcoming pneumococcalresistance |
Craig, W.A.; |
American Journal of Medicine Supplements |
2004-08-02 |
查看 |
| Treatment of acute bacterial rhinosinusitis caused byantimicrobial-resistant Streptococcus pneumoniae |
Anon, J.B.; |
American Journal of Medicine Supplements |
2004-08-02 |
查看 |
| Measurement and expression of risk: Optimizing decision strategies |
Irvine, E.J.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Aging, the gastrointestinal tract, and risk of acid-related disease |
Greenwald, D.A.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Therapeutic choices in reflux disease: Defining the criteria for selectinga proton pump inhibitor |
Freston, J.W.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Gastroesophageal reflux disease: Could intervention in childhood reduce therisk of later complications? |
Gold, B.D.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Appropriate strategies for testing and treating Helicobacter pylori inchildren: When and how? |
Sherman, P.M.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Endoscopy-negative reflux disease: Concepts and clinical practice |
Chey, W.D.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Management of acid-related disorders in patients with dysphagia |
Howden, C.W.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Managing gastroesophageal reflux disease for the lifetime of the patient:Evaluating the long-term options |
Metz, D.C.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Extraesophageal symptoms: What role for the proton pump inhibitors? |
Nord, H.J.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Prevention of nonsteroidal anti-inflammatory drug-associatedgastrointestinal symptoms and ulcer complications |
Peura, D.A.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Cardioprotective effects and gastrointestinal risks of aspirin: Maintainingthe delicate balance |
Kimmey, M.B.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Barrett esophagus: Will effective treatment prevent the risk of progressionto esophageal adenocarcinoma? |
Sharma, P.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Will eradication of Helicobacter pylori infection influence the risk ofgastric cancer? |
Hunt, R.H.; |
American Journal of Medicine Supplements |
2004-09-06 |
查看 |
| Immunomodulatory properties of macrolides: Overview and historicalperspective |
Rubin, B.K.; |
American Journal of Medicine Supplements |
2004-11-08 |
查看 |
| Clinical implications of the immunomodulatory effects of macrolides |
Tamaoki, J.;Kadota, J.;Takizawa, H.; |
American Journal of Medicine Supplements |
2004-11-08 |
查看 |
| Applying lessons learned in the treatment of diffuse panbronchiolitis toother chronic inflammatory diseases |
Kudoh, S.; |
American Journal of Medicine Supplements |
2004-11-08 |
查看 |
| Clinical implications of the immunomodulatory effects of macrolides onsinusitis |
Majima, Y.; |
American Journal of Medicine Supplements |
2004-11-08 |
查看 |
| Immunomodulatory effects of macrolides: Implications for practicingclinicians |
Siddiqui, J.; |
American Journal of Medicine Supplements |
2004-11-08 |
查看 |
| Epidemiology of diabetes mellitus and associated cardiovascular riskfactors: Focus on human immunodeficiency virus and psychiatric disorders |
Zimmet, P.; |
American Journal of Medicine Supplements |
2005-04-01 |
查看 |
| Evaluation of the patient with diabetes mellitus and suspected coronaryartery disease |
Heller, G.V.; |
American Journal of Medicine Supplements |
2005-04-01 |
查看 |
| The epidemiology of migraine |
Lipton, R.B.;Bigal, M.E.; |
American Journal of Medicine Supplements |
2005-03-01 |
查看 |
| Identifying migraine in primary care settings |
Sadovsky, R.;Dodick, D.W.; |
American Journal of Medicine Supplements |
2005-03-01 |
查看 |
| Initiating and optimizing acute therapy for migraine: The role ofpatient-centered stratified care |
Diamond, M.;Cady, R.; |
American Journal of Medicine Supplements |
2005-03-01 |
查看 |
| Metabolic issues and cardiovascular disease in patients withpsychiatric disorders |
Casey, D.E.; |
American Journal of Medicine Supplements |
2005-04-01 |
查看 |
| Evaluating the triptans |
Mathew, N.T.;Loder, E.W.; |
American Journal of Medicine Supplements |
2005-03-01 |
查看 |
| Evaluating the safety and tolerability profile of acute treatments formigraine |
Martin, V.T.;Goldstein, J.A.; |
American Journal of Medicine Supplements |
2005-03-01 |
查看 |
| Metabolic syndrome and cardiovascular disease in patients with humanimmunodeficiency virus |
Grinspoon, S.K.; |
American Journal of Medicine Supplements |
2005-04-01 |
查看 |
|
|
